FOR IMMEDIATE RELEASE:
CONTACT: Val Kogan, MARBC President
October 25, 2010
tel: (484) 467-7444, e-mail: val@ma-rbc.org
1st International Adam Smith Institute Forum
INNOVATIVE DRUG RESEARCH & DEVELOPMENT IN RUSSIA
Investing in the Future Growth of Pharmaceuticals, Bio-Tech and Clinical Trials
November 17-18, 2010, hotel “Marriott Royal Aurora”, Moscow
Mid-Atlantic - Russia Business Council is supporting the forum
and offers you 25% discount* on the attendance fee
http://www.adamsmithconferences.com/hr14mabc
This event is the only International Forum focusing on INNOVATIVE DRUG RESEARCH & DEVELOPMENT
IN RUSSIA and is designed to be a unique industry platform for discussion, debate and problem-solving for all
industry players that are either active or interested in the Russian innovative drug market.
The 40+ -strong speaker faculty features the top names from the Russian innovative drug market, including
key Governmental representatives and senior speakers from the leading institutions and organizations
investing in the sector, as well as Top-level executives from Russian innovative companies and multinational
corporations:
SPEAKERS CONFIRMED TO DATE:
 Sergey Tsyb, Director of Chemical and Technological Complex and Bioengineering Technologies Development,
Ministry of Industry and Trade of the Russian Federation
 Elena Telnova, Head, Federal Service for the Supervision of Healthcare and Social Development in the
Russian Federation
 Sergei Kolesnikov, Member or Russian Parliament, Deputy-Chairman of Committee for Health Care, State
Duma of the RF & President, National Innovative Technology Chamber
 Ivan Bortnik, Сhairman of the Supervisory Board, Fund for Promotion of Small Enterprises in the Scientific
and Technical Area
 Yury Krestinskiy, Director, Institute of Public Healthcare Development
 Andrey Ivaschenko, Chairman of the Board of Directors, The ChemRar High-Tech Center
 Dmitry Morozov, Chairman of the Board of Directors, BIOCAD
 Alexander Shuster, Chairman of the Board of Directors, Masterpharm
 Mikhail Mogutov, President, Bioprocess Holding of Bioprocess Group
 Gail Cassell, Vice President of Scientific Affairs, Eli Lilly & Company
 Hari Sven Krishnan, CPO Head / General Manager, Novartis Pharma
 Milos Petrovic, General Director, F. Hoffmann La Roche Russia
 James Class, Director, Global Public Policy, Merck
 Andrew Rudman, Associate Vice President, Pharmaceutical Research and Manufacturers of America
 Andrey Vvedensky, Director of Programmes and Projects Department, Russian Venture Company (RVC)
 Pini Ben–Elazar, CEO, Mor Research Applications
1760 MARKET STREET, SUITE 1100, PHILADELPHIA, PA 19103  TEL (215) 708-2628  FAX (215) 963-9104
HTTP://WWW.MA-RBC.ORG  INFO@MA-RBC.ORG  VAL@MA-RBC.ORG




























Mikhail Samsonov, Chief Scientific Officer, Russia, Novartis Pharma
Marat Fazylov, Head of Legal Protection of Licensing, IP Management, Valenta Pharmaceutical
Andrey Egorov, General Director, Sotex PharmFirm
Maxim Uvarov, General Director, Binnopharm
Gennady Shirshov, Executive Director, Society of Professional Pharmaceutical Organizations
Andrew Somers, President & CEO, American Chamber of Commerce in Russia
Alexey Konov, Vice-President, Group of Companies BIOPROCESS & Director on investments in biotechnology,
Venture Fund Bioprocess Capital Ventures
Dmitry Popov, Managing Partner, Maxwell Asset Management
Elena Volskaya, Head, Russian Ethical Committee
Andrey Belashov, General Director, Segmentapharm
Anna Harrington-Morozova, Director Global Regulatory Affairs APJEM, GlaxoSmithKline
Alexey Kovalenko, Chief Scientific Officer, Polysan
Tatyana Nikolenko, Director, Infrastructure Projects, The Russian Corporation of Nanotechnologies
(RUSNANO)
Leonid Gokhberg, First Pro-Rector, The Higher School of Economics
Larisa Popovich, Director, Health Economics Institute, The Higher School of Economics
Maxim Akimov, Deputy Governor, Kaluga Region
Igor Elfimov, Deputy Governor, Yaroslavl Region
Timur Shagivaleev, Chairman of the Board of Directors, Special economic Zone “ALABUGA”
Dmitry Khalilov, Partner, Head of the Pharmaceutical Group in the CIS, Ernst & Young
Igor Stefanov, Director, General Manager, Synergy Research Group
Svetlana Timofeeva, Director, Clinical Operations, Synergy Research Group
Jiří Heřmánek, Vice President & General Manager East Central Europe (Czech, Hungary, Russia, Slovakia),
Genzyme
Eric Rasmussen, Director, Industry, Commerce and Agribusiness Team, Russia, European Bank for
Reconstruction and Development
Evguenia Galanina, Associate Banker, Industry, Commerce and Agribusiness Team, Russia, European Bank
for Reconstruction and Development
Yuriy Oreshin, Partner, Teknoinvest Angelico Ventures
Anatoliy Grigoriev, Vice-president, Russian Academy of Sciences
Madina Torchinova, Director of Legal and Regulatory Affairs, Association of International Pharmaceutical
Manufacturers (AIPM)
Irina Ivanishcheva, Head of Legal Department, AstraZeneca
THE STEERING COMMITTEE INCLUDES:
 Gennady Shirshov, Executive Director, Society of Professional Pharmaceutical Organizations
 Andrew Somers, President & CEO, American Chamber of Commerce in Russia
 Sergei Kolesnikov, Member or Russian Parliament, Deputy-Chairman of Committee for Health Care, State Duma of
the RF & President, National Innovative Technology Chamber
 Dmitry Morozov, Chairman of the Board of Directors, BIOCAD
 Dr. Andrey Ivaschenko, Chairman of the Board of Directors, The ChemRar High-Tech Center
 Mikhail Mogutov, President, Bioprocess Holding of Bioprocess Group
 Irina Dorokhova, Senior Director, Government Affairs for Russia and CEE, Johnson & Johnson
 Olga Morozova, Director of Public and Corporate Affairs, Eli Lilly Russia
 Alexander Bykov, Director, External Affairs & Market Access, Teva Pharmaceuticals Russia
 Val Kogan, President, Mid-Atlantic - Russia Business Council
1760 MARKET STREET, SUITE 1100, PHILADELPHIA, PA 19103  TEL (215) 708-2628  FAX (215) 963-9104
HTTP://WWW.MA-RBC.ORG  INFO@MA-RBC.ORG  VAL@MA-RBC.ORG
2010 FORUM – FACTS & FIGURES:
 THE ONE AND ONLY conference covering the entire spectrum of issues related to innovative drugs
R&D in Russia
 6 Informative sessions, full of unique and topical information
 4 interactive panel discussions, focused on the most critical and timely topics
 5+ keynotes, featuring leading international speakers who will share their experience, opinions and
forecasts for innovation within the pharma market
 40+ Top industry speakers
 PLUS unlimited networking opportunities at social functions and via online networking tool EConnect, which allows you to pre-arrange meetings to maximise your time spent at the event.
KEY FEATURES & HIGHLIGHTS include:
 KEYNOTE SESSION: Strategic development of innovative drugs in Russia: plans, opportunities and
priorities for the future
 STRATEGIC FOCUS on domestic innovative companies
 SPECIAL SESSION on International pharmaceutical company strategies and their role in the
development of the Russian R&D sector
 LIVE DEBATE: Funding and opportunities for attracting investment to the sector
 EXTENDED SESSION on The creation and development of modern pharmaceutical industrial
clusters and medical innovation in the regions
 SPECIAL FOCUS: "CLINICAL RESEARCH IN RUSSIA: THE PRESENT AND THE FUTURE"
 Interactive discussion on the topic: "Human resources are all-important: how can the shortage of
highly qualified professionals be overcome?"
 INTERACTIVE WORKING GROUP on legal issues affecting the R&D sector in Russia and the
establishment of a regulatory framework for innovative technologies in the Russian pharmaceutical
industry
Full details about forum are on the website http://www.adamsmithconferences.com/hr14mabc
Discount details:
- 25% discount* - register using this link http://www.adamsmithconferences.com/hr14mabc or quote HR14SED
VIP code
- Register early and SAVE on “early bird” price – see website for details
For more information, please contact Val Kogan, President of the MARBC, by phone: (484) 467-7444,
by e-mail: val@ma-rbc.org, or visit the MARBC website: http://www.ma-rbc.org.
1760 MARKET STREET, SUITE 1100, PHILADELPHIA, PA 19103  TEL (215) 708-2628  FAX (215) 963-9104
HTTP://WWW.MA-RBC.ORG  INFO@MA-RBC.ORG  VAL@MA-RBC.ORG